La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

National HealthCare Résultats passés

Passé contrôle des critères 3/6

Les bénéfices de National HealthCare ont diminué à un taux annuel moyen de -1.4%, tandis que le secteur Healthcare a vu ses bénéfices augmenter de en à 7.1% par an. Les revenus ont augmenté de en à un taux moyen de 3.6% par an. Le rendement des capitaux propres de National HealthCare est 9.6% et ses marges nettes sont de 7.8%.

Informations clés

-1.4%

Taux de croissance des bénéfices

-1.5%

Taux de croissance du BPA

Healthcare Croissance de l'industrie	8.5%
Taux de croissance des recettes	3.6%
Rendement des fonds propres	9.6%
Marge nette	7.8%
Dernière mise à jour des bénéfices	30 Jun 2024

Mises à jour récentes des performances passées

Recent updates

Why We Think National HealthCare Corporation's (NYSEMKT:NHC) CEO Compensation Is Not Excessive At All

May 01

Returns On Capital At National HealthCare (NYSEMKT:NHC) Paint A Concerning Picture

Apr 09

Is National HealthCare Corporation (NYSEMKT:NHC) A Good Fit For Your Dividend Portfolio?

Mar 17

National HealthCare Corporation's (NYSEMKT:NHC) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Mar 02

National HealthCare Corporation (NYSEMKT:NHC) Insiders Have Been Selling

Feb 15

Reflecting on National HealthCare's (NYSEMKT:NHC) Share Price Returns Over The Last Year

Feb 02

Could The National HealthCare Corporation (NYSEMKT:NHC) Ownership Structure Tell Us Something Useful?

Jan 20

These Metrics Don't Make National HealthCare (NYSEMKT:NHC) Look Too Strong

Jan 07

Do These 3 Checks Before Buying National HealthCare Corporation (NYSEMKT:NHC) For Its Upcoming Dividend

Dec 25

What We Learned About National HealthCare's (NYSEMKT:NHC) CEO Pay

Dec 24

Is National HealthCare Corporation's (NYSEMKT:NHC) 3.1% Dividend Worth Your Time?

Dec 12

Does National HealthCare Corporation's (NYSEMKT:NHC) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?

Nov 30

Ventilation des recettes et des dépenses

Comment National HealthCare gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

NYSEAM:NHC Recettes, dépenses et bénéfices (USD Millions )
Date	Recettes	Les revenus	Dépenses G+A
30 Jun 24	1,172	92	42
31 Mar 24	1,163	81	42
31 Dec 23	1,135	67	42
30 Sep 23	1,105	45	40
30 Jun 23	1,087	32	40
31 Mar 23	1,075	19	41
31 Dec 22	1,074	22	41
30 Sep 22	1,079	32	41
30 Jun 22	1,074	31	41
31 Mar 22	1,051	133	41
31 Dec 21	1,011	139	41
30 Sep 21	989	150	40
30 Jun 21	961	167	40
31 Mar 21	950	90	40
31 Dec 20	978	42	40
30 Sep 20	985	28	41
30 Jun 20	994	35	41
31 Mar 20	1,004	20	41
31 Dec 19	996	68	41
30 Sep 19	990	73	41
30 Jun 19	989	74	41
31 Mar 19	984	83	41
31 Dec 18	979	59	41
30 Sep 18	977	62	41
30 Jun 18	972	52	41
31 Mar 18	968	41	41
31 Dec 17	964	56	40
30 Sep 17	956	49	41
30 Jun 17	947	48	41
31 Mar 17	936	50	41
31 Dec 16	924	51	41
30 Sep 16	923	51	41
30 Jun 16	917	51	41
31 Mar 16	914	49	40
31 Dec 15	907	46	40
30 Sep 15	899	44	40
30 Jun 15	892	45	40
31 Mar 15	884	45	40
31 Dec 14	872	45	40
30 Sep 14	852	46	40
30 Jun 14	830	54	40
31 Mar 14	805	55	39
31 Dec 13	789	56	39
30 Sep 13	773	55	39

Des revenus de qualité: NHC a un important ponctuel gain de $48.5M impactant ses 12 derniers mois de résultats financiers à 30th June, 2024.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de NHC (7.8%) sont supérieures à celles de l'année dernière (2.9%).

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: Les bénéfices de NHC ont diminué de 1.4% par an au cours des 5 dernières années.

Accélération de la croissance: La croissance des bénéfices de NHC au cours de l'année écoulée ( 187.7% ) dépasse sa moyenne sur 5 ans ( -1.4% par an).

Bénéfices par rapport au secteur d'activité: La croissance des bénéfices NHC au cours de l'année écoulée ( 187.7% ) a dépassé celle du secteur Healthcare 6%.

Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de NHC ( 9.6% ) est considéré comme faible.

National HealthCare Résultats passés

Passé contrôle des critères 3/6

Informations clés

Mises à jour récentes des performances passées

Second quarter 2024 earnings released: EPS: US$1.74 (vs US$1.06 in 2Q 2023)

First quarter 2024 earnings released: EPS: US$1.71 (vs US$0.76 in 1Q 2023)

Full year 2023 earnings released: EPS: US$4.36 (vs US$1.46 in FY 2022)

Third quarter 2023 earnings released: EPS: US$0.68 (vs US$0.16 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: US$1.06 (vs US$0.21 in 2Q 2022)

First quarter 2023 earnings released: EPS: US$0.76 (vs US$0.99 in 1Q 2022)

Recent updates

CEO & Director recently sold US$494k worth of stock

Independent Chairman exercised options to buy US$389k worth of stock.

Second quarter dividend of US$0.61 announced

Second quarter 2024 earnings released: EPS: US$1.74 (vs US$1.06 in 2Q 2023)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2024

Upcoming dividend of US$0.61 per share

First quarter dividend increased to US$0.61

National Healthcare Corporation Declares Quarterly Dividend, Payable on August 1, 2024

First quarter 2024 earnings released: EPS: US$1.71 (vs US$0.76 in 1Q 2023)

Independent Director exercised options to buy US$420k worth of stock.

National HealthCare Corporation, Annual General Meeting, May 09, 2024

Upcoming dividend of US$0.59 per share

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$4.36 (vs US$1.46 in FY 2022)

Third quarter dividend of US$0.59 announced

NHC Announces Quarterly Common Dividend, Payable on May 1, 2024

Independent Director exercised options to buy US$312k worth of stock.

Upcoming dividend of US$0.59 per share at 2.5% yield

Independent Chairman exercised options to buy US$290k worth of stock.

Independent Director recently sold US$641k worth of stock

Third quarter 2023 earnings released: EPS: US$0.68 (vs US$0.16 loss in 3Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on February 1, 2024

Independent Director exercised options to buy US$131k worth of stock.

Upcoming dividend of US$0.59 per share at 3.5% yield

Independent Chairman recently bought US$131k worth of stock

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: EPS: US$1.06 (vs US$0.21 in 2Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2023

Independent Director recently bought US$129k worth of stock

Upcoming dividend of US$0.59 per share at 3.9% yield

Independent Director recently bought US$135k worth of stock

National HealthCare Corporation Announces Quarterly Dividend, Payable on July 31, 2023

First quarter 2023 earnings released: EPS: US$0.76 (vs US$0.99 in 1Q 2022)

Upcoming dividend of US$0.57 per share at 4.1% yield

Independent Director recently bought US$125k worth of stock

Full year 2022 earnings released: EPS: US$1.46 (vs US$9.03 in FY 2021)

National Healthcare Corporation Declares Quarterly Dividend, Payable on May 1, 2023

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$106k worth of stock.

Independent Director recently sold US$211k worth of stock

Insufficient new directors

National HealthCare Corporation Announces Quarterly Dividend, Payable on February 1, 2023

Third quarter 2022 earnings released: US$0.16 loss per share (vs US$0.22 loss in 3Q 2021)

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$175k worth of stock.

National HealthCare Corporation (NYSEAM:NHC) announces an Equity Buyback for $25 million worth of its shares.

Second quarter 2022 earnings released: EPS: US$0.21 (vs US$6.83 in 2Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2022

Upcoming dividend of US$0.57 per share

Independent Chairman exercised options to buy US$135k worth of stock.

Independent Director exercised options to buy US$529k worth of stock.

First quarter 2022 earnings released: EPS: US$0.99 (vs US$1.39 in 1Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on August 1, 2022

Insufficient new directors

Upcoming dividend of US$0.55 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

National Healthcare Corporation Announces Quarterly Dividend, Payable on May 2, 2022

National HealthCare Corporation Appoints Sandra Y. Trail to Its Board of Director, Effective February 1, 2022

Independent Director exercised options to buy US$350k worth of stock.

Upcoming dividend of US$0.55 per share

CEO & Director exercised options and sold US$132k worth of stock

Third quarter 2021 earnings released: US$0.22 loss per share (vs US$0.84 profit in 3Q 2020)

Upcoming dividend of US$0.52 per share

Second quarter 2021 earnings released: EPS US$6.83 (vs US$1.85 in 2Q 2020)

Upcoming dividend of US$0.52 per share

Independent Director exercised options to buy US$567k worth of stock.

First quarter 2021 earnings released: EPS US$1.39 (vs US$1.76 loss in 1Q 2020)

National Healthcare Corporation Announces Quarterly Dividend, Payable on August 2, 2021

Independent Director exercised options to buy US$527k worth of stock.